China Medical Insurance Bureau Publishes List of Severely Dishonest Drug Firms

The credit-rating list matters less as a naming exercise than as a signal about how procurement access is now governed: dishonesty ratings tie directly to a firm's standing in the state pricing and bidding system, so the list functions as a de facto eligibility filter rather than reputational shaming. Firms still carrying 2020-benchmark ratings sit alongside those judged under the 2025 discretionary standard, meaning the list reflects two different vintages of enforcement. The open question is how quickly the legacy ratings clear and whether the discretionary benchmark tightens the practical bar for staying in procurement.